Gland Pharma shares gain on securing USFDA nod for blood pressure treatment drug

Gland Pharma Share Price | In a stock exchange filing, the company said it has received approval from the US drug regulator for Angiotensin II Acetate injection, 2.5 mg/mL, for treating blood pressure in adults with septic or other distributive shock.

Leave a Reply

Your email address will not be published. Required fields are marked *